Serenity (@aleabitoreddit)
Serenity — anonymous independent trader / X & Reddit KOL (real legal name not publicly disclosed; Reddit u/AleaBito, ex-r/wallstreetbets). Self-described former AI research scientist / RISC-V Foundation member; >500k X followers.
AI supply-chain 'chokepoint' theory: ignore the obvious mega-caps (NVDA, hyperscalers) and instead reverse-engineer the AI buildout to its narrow, irreplaceable upstream nodes — compound-semiconductor substrates, InP lasers, co-packaged optics/silicon photonics, MBE epitaxy gear, power semis — small-cap suppliers the buildout literally cannot proceed without. Likened to choke points such as the Strait of Hormuz for oil.
- Not a fund — A research, media or advisory business with no managed book to score.
- Self-reported — Headline returns are manager- or firm-reported and unaudited.
Top holdings
long — Signature/crown-jewel call. InP (indium phosphide) substrate chokepoint for photonics with claimed vertical integration of multiple upstream nodes; the trade that got him banned from WSB and the one he calls his most legendary (claimed ~1000%+ paper gain).
long — Highest-conviction name; external continuous-wave DFB laser light source for co-packaged optics (CPO) — a chokepoint input as optical interconnect replaces copper. Claimed ~19x.
long — Specialty foundry — photonics + 800 VDC power semis (NVDA exposure via NVTS/POWI), only high-volume SiC foundry in the US; EU CHIPS Act 2 catalyst. His 2026-05-27 post drove a 70%+ rally with no company news (Bloomberg/Reuters-covered) — the clearest proof of his market impact.
long — Vertically integrated optical transceiver / external-light-source play on the laser→design→assembly chain feeding CPO and datacenter optics.
long — European 'NeoCloud' AI GPU/Rubin cloud capacity; called as a 'mechanical panic' misprice vs multi-billion 2026 revenue guidance and net cash.
long — Long-term core; custom-silicon + optical DSP beneficiary of the CPO/optical-interconnect shift validated by NVDA's ~$2B optical investment.
long — Burn-in / test layer of the photonics & compound-semi supply chain — a pre-mass-volume chokepoint on yield.
Datacenter optics / transceivers for AI networking
Recent moves
May 2026: posted a long thesis on X-Fab ($XFAB) — photonics + 800 VDC power semis (NVTS/POWI), only high-volume US SiC foundry, EU CHIPS Act 2 catalyst — triggering a 70%+ intraday rally on ~17x average volume with no company news (Bloomberg/Reuters covered it). Has publicly noted de-risking (unwinding margin toward zero) around the mid-2026 Iran/geopolitical and policy uncertainty, and floated energy-war longs (LNG, CVX). Continues to surface small-cap silicon-photonics / CPO / compound-semi names (FOCI, Riber, Soitec) as chokepoint candidates.
Our take
A high-conviction retail KOL with a genuinely interesting, technically literate chokepoint framework and demonstrable market-moving influence (the Bloomberg/Reuters-covered XFAB rally is real). But the returns are self-reported, unaudited, leveraged, and wildly volatile, the book is hyper-concentrated in illiquid micro-caps, and there is acute keyman/keyword risk plus prior pump-and-dump scrutiny. Included as a non-conventional 'viral' creator to track for idea flow and supply-chain mapping — not as an investable, verifiable fund.
The framework is the durable part; the record is not verifiable.
Chokepoint analysis is a legitimate, under-supplied lens — most AI supply-chain work stops at the second derivative (NVDA's suppliers), and mapping to InP substrate capacity or MBE tool lead times is real work few sell-side desks staff for. Our skepticism sits at the join between that lens and the reported P&L. Three things break attribution. Entry is self-fulfilling — a thesis post into a thin float creates part of the move it predicts, so the mark reflects flow as well as re-rating. Exit is not symmetric: selling size into a crowd you assembled is visible, and daily turnover in these names is small against the position sizes implied. And returns are levered at roughly 1.4x at variable times, so even an honest gross number isn't a clean skill signal. Correct use: an idea-generation input whose reasoning you re-derive yourself — published theses coincide with the account's own flow impact, so marks at publication are not a clean read on value.
Thesis
Not a fund — a pseudonymous individual's personal, levered book broadcast to a very large audience. The chokepoint framework (reverse-engineer the AI buildout to its narrow, irreplaceable upstream nodes) is technically literate and produced early calls. But record and influence are now inseparable: once one post moves a Paris-listed chipmaker 76–77% on ~17x average volume, the account's own marks are partly a function of its own distribution. That reflexivity, not the stock-picking, is the central problem.
Chokepoint theory: skip the obvious mega-caps (NVDA, hyperscalers) and buy the narrow upstream nodes the AI buildout cannot route around — InP substrates (AXTI), silicon photonics / CPO (SIVE, AAOI, LITE), compound-semi foundry (XFAB), MBE epitaxy, 800VDC power semis. Concentrated, small-cap, self-disclosed ~1.4x margin, discretionary de-levering on macro events (wound margin to zero during the mid-2026 Iran escalation).
Assessment
- Chokepoint framing is genuinely differentiated — maps AI capex to physical bottlenecks (InP substrate, epitaxy, CPO) that most AI supply-chain research never reaches.
- Technically literate on the underlying physics and process, not just ticker narrative — theses cite capacity, materials and design-win mechanics, which is checkable.
- Unusually transparent for a retail creator: publishes positions, conviction levels, margin usage, and de-levering decisions with dates.
- Discloses drawdowns as well as peaks (posted 'not doing so well anymore' after the +501% mark), which most performance-posting accounts do not.
- Return claims do not reconcile: ~+501% YTD, later ~+3,612% YTD, a third-party ~+4,502%, plus separate '225x in 2 years' and '45x' framings. Mutually inconsistent numbers are themselves the finding.
- All figures are self-reported and unaudited — no fund, no administrator, no 13F, no filer CIK, no brokerage verification. Zero independent confirmation of any return.
- Reflexivity: a post moved X-Fab 76–77% intraday on ~17x average volume, with the CEO stating no undisclosed material developments. Entry marks are partly self-created flow.
- Liquidity asymmetry: marks assume an exit a visible concentrated seller may not get. SIVE has re-rated to SEK ~12.1B (~$1.26B, 2026-07-21), but float turnover stays small against implied size.
- Levered and variably so (~1.4x, cut to zero on macro stress), so reported returns blend leverage with selection and cannot be decomposed from outside.
- 2026-07Stronger evidence since: on 17 Jul 2026 he posted a quantified -49.4% month plus a public de-levering — a far harder disclosure than the softer remark that followed the +501% mark.
Record
What is independently verified is price impact, not performance. Bloomberg and Reuters both covered the 2026-05-27 X-Fab move — up 76–77% intraday depending on source, volume ~17x the three-month average, shares halted repeatedly for volatility, and CEO Damien Macq stating the company was not aware of any undisclosed material developments warranting disclosure. That documents distribution power. The return side is all creator claim: ~+122% for the year to ~04/2026, ~+501% YTD at a May 2026 peak, ~+3,612% YTD as of 2026-06-11, a tracker citing ~+4,502% for 2026 — unaudited, levered, and since pulled back from peak by his own account. Earlier calls (AXTI reportedly ~$12 to ~$70 by March 2026) predate market-moving scale and are better evidence of skill, but equally unverified. Attribution is unresolvable publicly: skill, leverage, AI small-cap beta and self-created flow all point the same way here.
Risks & fit
- Key-person and platform risk is absolute: one pseudonymous individual, no disclosed legal name, no succession. Account suspension or deletion ends the entire information stream.
- Crowded-exit risk for followers — they concentrate into the same illiquid names at post-publication prices, the worst point on the flow curve.
- Criticism exists that posts function as promotion rather than research, including from a short seller; contested and unresolved. Bearing is on disclosure quality, not adjudication.
- Regime dependence: this is a levered bet on AI capex continuing. A buildout pause compresses these small-caps far harder than the mega-caps they proxy.
- No regulatory visibility of any kind — no 13F, no fund filings — so the actual book, its size and its turnover are entirely unobservable.
Our read — that the record is inseparable from reflexivity, leverage and illiquidity — fails on two things. First, audited statements showing net returns across full round trips, including realized exits at size in the small-caps, not peak paper marks. Second, evidence the chokepoint calls generated alpha before the follower base reached market-moving scale — the early AXTI entry is the test case, where a verified fill history would isolate selection from flow. The framework itself is vindicated separately if AXT InP volumes and Sivers design wins convert on schedule.
Useful as a research input for readers wanting AI supply-chain mapping below the mega-cap layer, who will re-derive every claim from primary sources — capacity disclosures, design wins, materials lead times. It is not a track record and there is nothing to invest in: no fund exists and no capital is accepted. Published theses coincide with the account's own flow impact, so treat each as a hypothesis to check rather than a mark of value.
No fee, no fund, no vehicle — the content is free and there is nothing to subscribe to or allocate into. The point is incentive, not cost: monetization is undisclosed, and the account is driven by attention rather than AUM.